Oral compositions of abt-263 for treating cancer

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/5377 (2006.01) A61K 47/10 (2006.01) A61K 47/44 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2708223

Methods of treating cancer using N-(4-(4-((2-(4-chlorophenyl)-5,5-dimethyl-1- cyclohex-1-en-1-yl)methyl)piper- azin-1-yl)benzoyl)-4-(((1R)-3-(morpholin-4-yl)-1- ((phenylsulfanyl)methyl)propyl)amino)-3-((trifluoromethyl)sulfonyl)benzene- sulfonamide are disclosed.

La présente invention concerne des procédés permettant de traiter le cancer à l'aide de N-(4-(4-((2-(4-chlorophényl)-5,5-diméthyl-1-cyclohex-1-en-1-yl)méthyl)pipérazin-1-yl)benzoyl)-4-(((1R)-3-(morpholin-4-yl)-1-((phenylsulfanyl)méthyl)propyl)amino)-3-((trifluorométhyl)sulfonyl)benzène sulfonamide.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Oral compositions of abt-263 for treating cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Oral compositions of abt-263 for treating cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oral compositions of abt-263 for treating cancer will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1561441

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.